Fulltext

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

Sawangjit R 1 , Chongmelaxme B , Phisalprapa P , Saokaew S , Thakkinstian A , Kowdley KV Show all authors , Chaiyakunapruk N

Affiliations 

  • 1 aClinical Pharmacy Research Unit (CPRU), Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand bSchool of Pharmacy, Monash University Malaysia, Selangor, Malaysia cCenter of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok dDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok eCenter of Health Outcome Research and Therapeutic Safety, School of Pharmaceutical Sciences,University of Phayao, Phayao fSection for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand gLiver Care Network and Organ Care Research, Swedish Medical Center, Seattle hSchool of Pharmacy, University of Wisconsin, Madison, WI iSchool of Population Health, University of Queensland, Brisbane, QLD, Australia
Medicine (Baltimore), 2016 Aug;95(32):e4529.
PMID: 27512874 DOI: 10.1097/MD.0000000000004529

Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) has significantly increased over the last decades. Despite existence of several interventions, there remains unclear which interventions work the best.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications